Safety and efficacy of combined melphalan percutaneous hepatic perfusion (M-PHP) and ipilimumab plus nivolumab (IPI+NIVO) in metastasized uveal melanoma (mUM): First results of the phase Ib part of the CHOPIN trial.
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Thaïs M.L. Tong, Mark C. Burgmans, Frank M. Speetjens, Arian R. van Erkel, Rutger W. van der Meer, Carla S.P. van Rijswijk, Mare A. Jonker, Inge C.F.M. Roozen, Jacob Lutjeboer, Els L. van Persijn-van Meerten, Christian H. Martini, Remco W.M. Zoethout, Fred G.J. Tijl, Christian U. Blank, Ellen Kapiteijn
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4281972309